More tricks with tetramers: A practical guide to staining T cells with peptide-MHC multimers

Immunology

Volumn 146, Issue 1, 2015, Pages 11-22

  Dolton, Garry ^a   Tungatt, Katie ^a   Lloyd, Angharad ^a   Bianchi, Valentina ^a   Theaker, Sarah M ^a   Trimby, Andrew ^a   Holland, Christopher J ^a   Donia, Marco ^b   Godkin, Andrew J ^a   Cole, David K ^a   Thor Straten, Per ^b   Peakman, Mark ^c   Svane, Inge Marie ^b   Sewell, Andrew K ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Peptide MHC dextramer; Peptide MHC tetramer; T cell; T cell receptor

Indexed keywords

DASATINIB; FLUOROCHROME; PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX MULTIMER; POLYMER; PROTEIN KINASE INHIBITOR; STREPTAVIDIN; TETRAMER; UNCLASSIFIED DRUG; ANTIBODY; FLUORESCENT DYE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; STAINING; SURFACE PLASMON RESONANCE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; PROCEDURES; PROTEIN MULTIMERIZATION;

ANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCENT DYES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; PROTEIN MULTIMERIZATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STAINING AND LABELING;

EID: 84938363499     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12499     Document Type: Review

References (53)

1. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J. T Cell antigen receptor recognition of antigen-presenting molecules. Annu Rev Immunol 2014; 33:169-200.
2. Attaf M, Legut M, Cole DK, Sewell AK. The T cell antigen receptor: the Swiss Army knife of the immune system. Clin Exp Immunol 2015; 181:1-18.
3. Wooldridge L, Lissina A, Cole DK, van den Berg HA, Price DA, Sewell AK. Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology 2009; 126:147-64.
4. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-6.
5. Fergusson JR, Smith KE, Fleming VM et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 2014; 9:1075-88.
6. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 2012; 36:142-52.
7. Newell EW, Sigal N, Nair N, Kidd BA, Greenberg HB, Davis MM. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol 2013; 31:623-9.
8. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73:975-83.
9. Appay V, Dunbar PR, Callan M et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
10. Klenerman P, Cerundolo V, Dunbar PR. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2002; 2:263-72.
11. Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK. A deep profiler's guide to cytometry. Trends Immunol 2012; 33:323-32.
12. Laugel B, van den Berg HA, Gostick E et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem 2007; 282:23799-810.
13. Dolton G, Lissina A, Skowera A et al. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells. Clin Exp Immunol 2014; 177:47-63.
14. Tungatt K, Bianchi V, Crowther MD et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol 2015; 194:463-74.
15. Lissina A, Ladell K, Skowera A et al. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods 2009; 340:11-24.
16. Cole DK, Pumphrey NJ, Boulter JM et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol 2007; 178:5727-34.
17. Aleksic M, Liddy N, Molloy PE, Pumphrey N, Vuidepot A, Chang KM, Jakobsen BK. Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies. Eur J Immunol 2012; 42:3174-9.
18. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. Structural and biophysical determinants of alphabeta T-cell antigen recognition. Immunology 2012; 135:9-18.
19. Sabatino JJ Jr, Huang J, Zhu C, Evavold BD. High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med 2011; 208:81-90.
20. Choi EM, Chen JL, Wooldridge L et al. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J Immunol 2003; 171:5116-23.
21. Choi EM, Palmowski M, Chen J, Cerundolo V. The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. J Immunol Methods 2002; 268:35-41.
22. Wooldridge L, Hutchinson SL, Choi EM et al. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J Immunol 2003; 171:6650-60.
23. Wooldridge L, Laugel B, Ekeruche J, Clement M, van den Berg HA, Price DA, Sewell AK. CD8 controls T cell cross-reactivity. J Immunol 2010; 185:4625-32.
24. Wooldridge L, Lissina A, Vernazza J et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol 2007; 37:1323-33.
25. Wooldridge L, Scriba TJ, Milicic A, Laugel B, Gostick E, Price DA, Phillips RE, Sewell AK. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers. Eur J Immunol 2006; 36:1847-55.
26. Wooldridge L, van den Berg HA, Glick M et al. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem 2005; 280:27491-501.
27. Massilamany C, Upadhyaya B, Gangaplara A, Kuszynski C, Reddy J. Detection of autoreactive CD4 T cells using major histocompatibility complex class II dextramers. BMC Immunol 2011; 12:40.
28. Cole DK, Edwards ES, Wynn KK et al. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J Immunol 2010; 185:2600-10.
29. Madura F, Rizkallah PJ, Holland CJ et al. Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides. Eur J Immunol 2015; 45:584-91.
30. Skowera A, Ellis RJ, Varela-Calvino R et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008; 118:3390-402.
31. Bulek AM, Cole DK, Skowera A et al. Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol 2012; 13:283-9.
32. Cole DK, Yuan F, Rizkallah PJ et al. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem 2009; 284:27281-9.
33. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72:8463-71.
34. Stewart SA, Dykxhoorn DM, Palliser D et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003; 9:493-501.
35. Hadrup SR, Bakker AH, Shu CJ et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 2009; 6:520-6.
36. Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007; 204:595-603.
37. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995; 375:148-51.
38. Clement M, Ladell K, Ekeruche-Makinde J et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol 2011; 187:654-63.
39. Daniels MA, Jameson SC. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J Exp Med 2000; 191:335-46.
40. Holman PO, Walsh ER, Jameson SC. Characterizing the impact of CD8 antibodies on class I MHC multimer binding. J Immunol 2005; 174:3986-91.
41. Purbhoo MA, Li Y, Sutton DH et al. The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol Cancer Ther 2007; 6:2081-91.
42. Laugel B, Price DA, Milicic A, Sewell AK. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur J Immunol 2007; 37:905-13.
43. Whelan JA, Dunbar PR, Price DA et al. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J Immunol 1999; 163:4342-8.
44. de Jong A, Cheng TY, Huang S et al. CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Immunol 2014; 15:177-85.
45. Kasmar AG, Van Rhijn I, Magalhaes KG et al. Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J Immunol 2013; 191:4499-503.
46. Kasmar AG, van Rhijn I, Cheng TY et al. CD1b tetramers bind alphabeta T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 2011; 208:1741-7.
47. Van Rhijn I, Kasmar A, de Jong A et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 2013; 14:706-13.
48. Ly D, Kasmar AG, Cheng TY et al. CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med 2013; 210:729-41.
49. Sidobre S, Kronenberg M. CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J Immunol Methods 2002; 268:107-21.
50. Gadola SD, Karadimitris A, Zaccai NR, Salio M, Dulphy N, Shepherd D, Jones EY, Cerundolo V. Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells. Philos Trans R Soc Lond B Biol Sci 2003; 358:875-7.
51. Karadimitris A, Gadola S, Altamirano M et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A 2001; 98:3294-8.
52. Corbett AJ, Eckle SB, Birkinshaw RW et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 2014; 509:361-5.
53. Attaf M, Huseby E, Sewell AK. alphabeta T cell receptors as predictors of health and disease. Cell Mol Immunol 2015;. doi:10.1038/cmi.2014.134.